• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清铁蛋白与非酒精性脂肪性肝病:荟萃分析和系统评价。

Serum Ferritin and Non-alcoholic Fatty Liver Disease: A Meta-analysis and Systematic Review.

机构信息

The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.

The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China; Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.

出版信息

Turk J Gastroenterol. 2023 Sep;34(9):952-960. doi: 10.5152/tjg.2023.22453.

DOI:10.5152/tjg.2023.22453
PMID:37674440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10542485/
Abstract

BACKGROUND/AIMS: Previous studies have shown that hyperferritinemia is a common phenomenon in non-alcoholic fatty liver dis- ease patients. We aim to further explore the relationship between serum ferritin levels and non-alcoholic fatty liver disease using a meta-analysis.

MATERIALS AND METHODS

Four Library databases were electronically searched from inception until December 2021 to find prospective cohort or case-control studies examining the relationship between serum ferritin levels and non-alcoholic fatty liver disease, and all kinds of literature were screened according to the inclusion and exclusion criteria. The odds ratio and other related data were extracted, and a meta-analysis was performed.

RESULTS

Eleven studies examining the relationship between serum ferritin levels and non-alcoholic fatty liver disease were included. The serum ferritin levels in the non-alcoholic fatty liver disease group were significantly higher than those without non-alcoholic fatty liver disease group (1.54 ng/mL, 95% CI: 0.85-2.23, P < .001). Serum ferritin levels were significantly associated with the risk of non-alcoholic fatty liver disease in both men and women (odds ratio = 2.36, 95% CI: 1.41-3.93, P = .001 and odds ratio = 2.93, 95% CI: 1.83-4.69, P < .001, respectively), and after adjusting for the parameters, the relationships were still shown to be significant in men and women (odds ratio = 2.24, 95% CI: 1.64-3.05, P < .001 and odds ratio = 3.30, 95% CI: 2.13-5.11, P < .001, respectively).

CONCLUSION

Serum ferritin levels were higher in patients with non-alcoholic fatty liver disease than in those without non-alcoholic fatty liver disease and were associated with the risk of non-alcoholic fatty liver disease in both men and women.

摘要

背景/目的:既往研究表明,高血清铁蛋白血症是非酒精性脂肪性肝病患者的常见现象。我们旨在通过荟萃分析进一步探讨血清铁蛋白水平与非酒精性脂肪性肝病之间的关系。

材料和方法

从建库至 2021 年 12 月,我们通过电子检索四个数据库,以查找前瞻性队列或病例对照研究,来检验血清铁蛋白水平与非酒精性脂肪性肝病之间的关系,并根据纳入和排除标准筛选各种文献。提取比值比和其他相关数据,并进行荟萃分析。

结果

纳入了 11 项检验血清铁蛋白水平与非酒精性脂肪性肝病之间关系的研究。非酒精性脂肪性肝病组的血清铁蛋白水平明显高于非酒精性脂肪性肝病组(1.54ng/ml,95%CI:0.85-2.23,P<.001)。血清铁蛋白水平与男性和女性非酒精性脂肪性肝病的发病风险显著相关(比值比=2.36,95%CI:1.41-3.93,P=.001和比值比=2.93,95%CI:1.83-4.69,P<.001),并且在调整参数后,这种关系在男性和女性中仍然显著(比值比=2.24,95%CI:1.64-3.05,P<.001和比值比=3.30,95%CI:2.13-5.11,P<.001)。

结论

与非酒精性脂肪性肝病患者相比,非酒精性脂肪性肝病患者的血清铁蛋白水平更高,且与男性和女性的非酒精性脂肪性肝病发病风险相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/5ed7955fa614/tjg-34-9-952_f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/674c3991c3c7/tjg-34-9-952_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/17feb6d3391f/tjg-34-9-952_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/0c557b4203ab/tjg-34-9-952_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/fc3ef763ae94/tjg-34-9-952_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/5ed7955fa614/tjg-34-9-952_f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/674c3991c3c7/tjg-34-9-952_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/17feb6d3391f/tjg-34-9-952_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/0c557b4203ab/tjg-34-9-952_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/fc3ef763ae94/tjg-34-9-952_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed4/10542485/5ed7955fa614/tjg-34-9-952_f005.jpg

相似文献

1
Serum Ferritin and Non-alcoholic Fatty Liver Disease: A Meta-analysis and Systematic Review.血清铁蛋白与非酒精性脂肪性肝病:荟萃分析和系统评价。
Turk J Gastroenterol. 2023 Sep;34(9):952-960. doi: 10.5152/tjg.2023.22453.
2
Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.血清铁蛋白与非酒精性脂肪性肝病的关系:一项荟萃分析。
Lipids Health Dis. 2017 Dec 2;16(1):228. doi: 10.1186/s12944-017-0613-4.
3
The association between serum ferritin level, microalbuminuria and non-alcoholic fatty liver disease in non-diabetic, non-hypertensive men.血清铁蛋白水平、微量白蛋白尿与非糖尿病、非高血压男性非酒精性脂肪性肝病的关系。
Clin Exp Hypertens. 2014;36(6):380-5. doi: 10.3109/10641963.2013.827704. Epub 2013 Sep 18.
4
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease.评估血清铁蛋白和肝铁与非酒精性脂肪性肝病严重程度的相关性。
Liver Int. 2019 Jul;39(7):1325-1334. doi: 10.1111/liv.14096. Epub 2019 Mar 27.
5
Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men.血清铁蛋白水平可预测健康韩国男性非酒精性脂肪性肝病的发生。
Metabolism. 2012 Aug;61(8):1182-8. doi: 10.1016/j.metabol.2012.01.007. Epub 2012 Mar 3.
6
Association of serum ferritin levels with non-alcoholic fatty liver disease in postmenopausal women.绝经后女性血清铁蛋白水平与非酒精性脂肪性肝病的关联
Climacteric. 2018 Oct;21(5):509-514. doi: 10.1080/13697137.2018.1493451. Epub 2018 Aug 14.
7
Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients.2型糖尿病患者的血清铁蛋白水平、微量白蛋白尿与非酒精性脂肪性肝病
Diabetes Metab Syndr. 2019 May-Jun;13(3):2226-2229. doi: 10.1016/j.dsx.2019.05.030. Epub 2019 May 25.
8
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.铜蓝蛋白基因变异与非酒精性脂肪性肝病患者的高血铁蛋白血症和肝脏铁含量增加有关。
J Hepatol. 2021 Sep;75(3):506-513. doi: 10.1016/j.jhep.2021.03.014. Epub 2021 Mar 24.
9
Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up.血清铁蛋白升高与非酒精性脂肪性肝病 16 年随访后的死亡率升高相关。
Liver Int. 2016 Nov;36(11):1688-1695. doi: 10.1111/liv.13144. Epub 2016 Apr 28.
10
Serum Iron:Ferritin Ratio Predicts Healthy Body Composition and Reduced Risk of Severe Fatty Liver in Young Adult Women.血清铁:铁蛋白比值可预测年轻成年女性的健康身体成分和降低严重脂肪肝风险。
Nutrients. 2017 Aug 4;9(8):833. doi: 10.3390/nu9080833.

引用本文的文献

1
Serum ferritin and risk of stroke: a meta-analysis of observation studies.血清铁蛋白与中风风险:观察性研究的荟萃分析
Front Neurol. 2025 Jul 1;16:1539407. doi: 10.3389/fneur.2025.1539407. eCollection 2025.
2
The regulatory effect of blood group on ferritin levels in aging: a retrospective study.血型对老年人铁蛋白水平的调节作用:一项回顾性研究。
PeerJ. 2025 Apr 14;13:e19281. doi: 10.7717/peerj.19281. eCollection 2025.
3
Effectiveness and risks of dapagliflozin in treatment for metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: a randomized controlled trial.

本文引用的文献

1
The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults.非酒精性脂肪性肝病与美国成年人血清铁蛋白水平的关系。
J Clin Lab Anal. 2022 Feb;36(2):e24225. doi: 10.1002/jcla.24225. Epub 2022 Jan 7.
2
A new perspective on NAFLD: Focusing on lipid droplets.非酒精性脂肪性肝病的新视角:聚焦脂滴
J Hepatol. 2022 Apr;76(4):934-945. doi: 10.1016/j.jhep.2021.11.009. Epub 2021 Nov 15.
3
Serum ferritin is correlated with non-alcoholic fatty liver disease in middle-aged and older patients with type 2 diabetes.
达格列净治疗2型糖尿病合并代谢功能障碍相关脂肪性肝病的有效性和安全性:一项随机对照试验
Front Med (Lausanne). 2025 Mar 25;12:1542741. doi: 10.3389/fmed.2025.1542741. eCollection 2025.
4
Effects of a Two-Year Lifestyle Intervention on Intrahepatic Fat Reduction and Renal Health: Mitigation of Inflammation and Oxidative Stress, a Randomized Trial.一项为期两年的生活方式干预对肝内脂肪减少和肾脏健康的影响:减轻炎症和氧化应激,一项随机试验
Antioxidants (Basel). 2024 Jun 21;13(7):754. doi: 10.3390/antiox13070754.
5
Associations of Ultrasound Findings with Serum Iron and Ferritin Levels in Children with Obesity.肥胖儿童超声检查结果与血清铁和铁蛋白水平的相关性
Life (Basel). 2024 Apr 7;14(4):484. doi: 10.3390/life14040484.
血清铁蛋白与中老年2型糖尿病患者的非酒精性脂肪性肝病相关。
Endocr Connect. 2021 Nov 29;10(12):1560-1569. doi: 10.1530/EC-21-0367.
4
Advancing the global public health agenda for NAFLD: a consensus statement.推进非酒精性脂肪性肝病的全球公共卫生议程:共识声明。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27.
5
Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review.代谢组学对理解非酒精性脂肪性肝病和非酒精性脂肪性肝炎综合征的贡献:一项系统综述。
Metabolites. 2021 Oct 11;11(10):694. doi: 10.3390/metabo11100694.
6
The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression.线粒体功能障碍和肝衰老在非酒精性脂肪性肝病发生和进展中的作用。
Biomed Pharmacother. 2021 Oct;142:112041. doi: 10.1016/j.biopha.2021.112041. Epub 2021 Aug 16.
7
Management of NAFLD patients with advanced fibrosis.非酒精性脂肪性肝病伴纤维化患者的管理。
Liver Int. 2021 Jun;41 Suppl 1:95-104. doi: 10.1111/liv.14847.
8
NAFLD and NASH and Diabetes.非酒精性脂肪性肝病、非酒精性脂肪性肝炎与糖尿病。
Diabetes Technol Ther. 2021 Jun;23(S2):S198-S205. doi: 10.1089/dia.2021.2515.
9
Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome.铁状态通过肠道微生物群影响肥胖的非酒精性脂肪肝疾病。
Microbiome. 2021 May 7;9(1):104. doi: 10.1186/s40168-021-01052-7.
10
Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions.肠道微生物群与非酒精性脂肪性肝病:发病机制、微生物群特征及治疗干预
Microorganisms. 2021 Apr 29;9(5):957. doi: 10.3390/microorganisms9050957.